Hormone replacement therapy [topp]
Inflammation [patf]
Sensitive [ftcn]
Proteins [aapp, bacs]
Post-Menopause [orgf]
Women [popg]
Type 2 Diabetes [dsyn]
Test [lbpr]
Oral [spco]
Hormone replacement therapy [topp]
Plasma C-reactive protein [aapp]
Soluble Vascular Cell Adhesion Molecule 1 [lbpr]
soluble [celc]
Intercellular adhesion molecule 1 [aapp, imft]
IL6 [aapp, imft]
Concentrations [menp]
Leukocyte Count [lbpr]
Post-Menopause [orgf]
Women [popg]
Type 2 Diabetes [dsyn]
Methods [inpr]
Post-Menopause [orgf]
Women [popg]
Type 2 Diabetes [dsyn]
N NOS [aapp, imft]
randomized [resa]
DOUBLE BLIND [resa]
Receive [qlco]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
N NOS [aapp, imft]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg day [qnco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg day [qnco]
placebo [topp]
N NOS [aapp, imft]
months [tmco]
Study [mnob]
variables [qlco]
Measured [qlco]
baseline [bodm]
End [spco]
Study [mnob]
Eight [qnco]
Women [popg]
randomized [resa]
Hormone replacement therapy [topp]
Women [popg]
Assigned [ftcn]
placebo [topp]
Group [idcn]
Dropped [acty]
Study [mnob]
Plasma C-reactive protein [aapp]
Increased [qnco]
mg/L [qnco]
mg/L [qnco]
P NOS [aapp, imft]
Women [popg]
treated [topp]
Hormone replacement therapy [topp]
N NOS [aapp, imft]
Compared [acty]
placebo [topp]
N NOS [aapp, imft]
Take [hlca]
baseline [bodm]
C-reactive protein [aapp, imft]
Body Mass Index [diap]
Smoking Status [clna]
account [idcn]
Plasma [bdsu]
Cell Adhesion Molecules [aapp, bacs]
IL6 [aapp, imft]
Leukocyte Count [lbpr]
Study [mnob]
Conclusions [idcn]
findings [ftcn]
Oral [spco]
Hormone replacement therapy [topp]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Plasma C-reactive protein level [lbpr]
Global [spco]
Inflammatory [ftcn]
activity [dora]
Post-Menopause [orgf]
diabetic [fndg]
Women [popg]
Plasma C-reactive protein [aapp]
Cardiovascular event [fndg]
